Senti Biosciences's total assets for Q3 2023 were $131.77M, a decrease of -8.26% from the previous quarter. SNTI total liabilities were $48.83M for the fiscal quarter, a 5.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.